共 173 条
[1]
Mohd Hanafiah K(2013)Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence Hepatology 57 1333-1342
[2]
Groeger J(2012)Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2095-2128
[3]
Flaxman AD(2013)Epidemiology and natural history of HCV infection Nat Rev Gastroenterol Hepatol 10 553-562
[4]
Wiersma ST(2013)Global control of hepatitis C: where challenge meets opportunity Nat Med 19 850-858
[5]
Lozano R(2012)The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007 Ann Intern Med 156 271-278
[6]
Naghavi M(2014)Direct-acting antiviral agents and the path to interferon independence Clin Gastroenterol Hepatol 12 728-737
[7]
Foreman K(2013)Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals Hepatology 58 1598-1609
[8]
Lim S(2014)The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis PLoS One 9 e101554-380
[9]
Shibuya K(2013)Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges Futur Virol 8 371-414
[10]
Aboyans V(2012)Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine Lancet Infect Dis 12 408-298